Third Quarter 2021 Summary *Reported sales grew 9%, primarily driven by double-digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth *Core sales (excluding currency effects) increased 8% *Pharma sales declined slightly compared to the prior year *Reported net income totaled $47 million *Acquisition Updates: -Completed the acquisition of 80% of Weihai Hengyu Medical Products, adding elastomeric and plastic component manufacturing capabilities in China for injectable drug delivery -Completed the acquisition of a majority stake in Voluntis, a provider of digital therapeutic solutions
The third-party certification verifies mass balance chain of custody and traceability from raw materials to finished products. Given this, Pregis can produce films classified as advanced recycled (circular, bio-circular and/or bio-based).
Ryan Wolcott, chief sustainability officer, explains the significance of this achievement, “Obtaining ISCC PLUS certifications for two additional facilities is a pivotal step in furthering our circular economy goals. This certification validates our ongoing investments in product development and our commitment to sustainability and lowering greenhouse gas emissions. This step represents one more path toward overcoming plastic waste and our goals of incorporating recycled content into our products through both mechanically recycled and advanced recycled sources.”
Earlier this year, Pregis launched the industry’s first high-pressure and high-performance cushioning film using 80% post-consumer recycled content generated from mechanically recycled resins. The ability to engineer film formulations that align closely with customers’ sustainability and performance objectives maintains the company’s position as an industry innovator.
more at: https://www.pregis.com/knowledge-hub/pregis-achieves-iscc-plus-certification-in–hopkinsville-kentucky-and-visalia-california-facilities/